Back
SPDR® S&P® Global Infrastructure ETF Vs. Aligos Therapeutics Industry Stock Comparison
Buy
51
GII
SPDR® S&P® Global Infrastructure ETF
Last Price:
61.30
Seasonality Move:
-0.87%
Buy
75
ALGS
Aligos Therapeutics
Last Price:
34.48
Seasonality Move:
10.65%
Buy
51
SPDR® S&P® Global Infrastructure ETF (GII)
is a Buy
Is SPDR® S&P® Global Infrastructure ETF a Buy, Sell or Hold?
- The current SPDR® S&P® Global Infrastructure ETF [GII] share price is $61.31. The Score for GII is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- GII is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GII Stock Price Chart
What is SPDR® S&P® Global Infrastructure ETF's stock price today?
-
The SPDR® S&P® Global Infrastructure ETF share price today is $61.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GII is experiencing slight selling pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $34.53
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
GII Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 42.66 | Sell |
Chaikin Money Flow: | -6496 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (61.23 - 62.83) | Sell |
Bollinger Bands (100): | (58.28 - 62.5) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.71 | Buy |
Relative Strength Index (14 RSI): | 85.17 | Buy |
Chaikin Money Flow: | 491004 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.08 - 27.66) | Buy |
Bollinger Bands (100): | (7.67 - 19.61) | Buy |
GII Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.15 | Sell |
20-day SMA: | 62.2 | Sell |
50-day SMA: | 61.91 | Sell |
200-day SMA: | 57.52 | Buy |
8-day EMA: | 62.02 | Sell |
20-day EMA: | 62.12 | Sell |
50-day EMA: | 61.64 | Sell |
200-day EMA: | 58.3 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.48 | Buy |
20-day SMA: | 23.64 | Buy |
50-day SMA: | 14.76 | Buy |
200-day SMA: | 15.86 | Buy |
8-day EMA: | 28.77 | Buy |
20-day EMA: | 23.99 | Buy |
50-day EMA: | 18.16 | Buy |
200-day EMA: | 16.13 | Buy |
SPDR® S&P® Global Infrastructure ETF Earnings Growth & GII Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
SPDR® S&P® Global Infrastructure ETF Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |